SciNeuro
PrivateLast Round
Series B
Dec 4, 2025
Total Funding Raised
$158M
Company Overview
SciNeuro Pharmaceuticals is a biotechnology company dedicated to developing innovative drugs that transform the treatment of CNS diseases, focusing on evidence-based targets to enhance patient outcomes and quality of life.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SciNeuro Comps
Public and private peers based on sector, stage, and business model.
SciNeuro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 4, 2025 | ||||
| Grant | Nov 20, 2025 | ||||
| Series A | Dec 8, 2020 |
Key People
Founding team and executive leadership
SciNeuro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyu Capital | Series A |
| Zoo Capital | Series A |
| TF Capital | Series A |
| ARCH Venture Partners | Grant |
| ARCH Venture Partners | Series B, Series A |
| Sequoia Capital | Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Developing a new de novo amyloid beta antibody program in collaboration with Novartis.
- Jan 12, 2026
Exclusive worldwide licensing deal with Novartis Pharma AG for Alzheimer's drug.
SciNeuro Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SciNeuro's valuation, stock price, and market status.
